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Abstract
Background The buccal space is an unusual location of malignancies. We report here the case of a woman with a melanoma 
metastasis in buccal fat pad, to evaluate the imaging features which might lead to the correct, although uncommon, diagnosis.
Case presentation A 71-year-old woman presented with a painless visible swelling of the left cheek. MRI revealed the pres-
ence of a solid lesion located in the buccal fat pad with features suggestive of malignancy. It showed T1 hyperintensity and 
T2 hypointensity, and restriction of diffusion. Histological examination showed neoplastic cells compatible with melanoma.
Discussion The lesion features (T1 hyperintensity and T2 hypointensity) initially lead our team to believe that there was a 
hemorrhagic component, possibly a residue of the biopsy. However, when associated with other malignancy features, such 
as low apparent diffusion coefficient (ADC) values and contrast enhancement, they should evoke the suspect of melanoma, 
provided that no biopsy was performed and no trauma occurred in the 3–7 days before.
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The buccal space is one of the deep anatomical compart-
ments of the head and neck regions, enveloped by the super-
ficial layer of the deep cervical fascia (Fig. 1). It is delimited 
medially by the buccinator muscle, laterally by the platysma 
muscle, anteriorly by the mimic muscles, and posteriorly 
by the mandible, medial and lateral pterygoid muscles, and 
parotid and masseter muscle [1, 2].
Most of the buccal space is occupied by adipose tissue—
the buccal fat pad—which laterally follows the parotid duct 
ending near the anterolateral portion of the parotid gland; 
medially, it projects towards the mandible and maxillary 
sinus; superiorly, it is divided by the temporal muscle into a 
superficial and deep portion and by the parotid duct into an 
anterior and posterior portion [3].
The buccal space frequently communicates with the pos-
terior masticatory space and with the infratemporal space; 
moreover, there is no real lower boundary with the subman-
dibular space. This anatomical space can thus function as a 
conduit to spread infectious or tumoral tissue between the 
mouth and the parotid gland.
Buccal space lesions are usually associated with cheek 
mass or facial swelling [4].
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Beside inflammatory manifestations and developmental 
lesions such as accessory parotid tissue (present in up to 
20% of the population), dermoid cysts, and vascular mal-
formations, a variety of tumors can occur in the buccal 
space [5].
The most common tumor processes localized in this 
area arise from minor salivary glands such as pleomor-
phic adenoma (PA), adenoid cystic carcinoma, acinic cell 
carcinoma, and mucoepidermoid carcinoma. Other tumors 
can originate from connective, muscular, neural, and lym-
phatic tissue, such as rhabdomyosarcomas and neurofi-
bromas [5].
Metastatic lesions in this region are a very rare occur-
rence, accounting for less than 1% of oral cavity malignan-
cies [6]. They are most commonly located in bony struc-
tures, particularly the mandible, while only about 33% are 
found in soft tissues [7]. Metastatic lesions can often be 
the first sign of a widespread malignant disease, generally 
indicating poor outcome [8]. However, there are only a 
few studies focusing on metastatic lesions in the buccal 
and masticatory space, and even less literature regarding 
malignant melanoma metastases in this region; moreover, 
most studies were carried out from a surgical standpoint 
[9–13].
We report here the case of a female patient, with nega-
tive oncological history, who presented to our unit with a 
swelling of the left cheek, which revealed to be a mela-
noma metastasis only after surgical exeresis.
We analyze our experience with a revision of the litera-
ture, aiming for a retrospective evaluation of the diagnostic 
imaging characteristics which might be useful in guid-
ing the differential diagnosis, to set an example to avoid 
repeating the same error in the future and to be of help to 
those who will find themselves in such a situation.
Case report
A 71-year-old woman presented with a painless visible 
swelling of the left cheek. Skin and oral mucosa were 
intact and of normal color. At palpation, the mass was 
mobile and apparently not adherent to the cutaneous and 
mucosal tissue.
For what concerns comorbidities, the patient was only 
known for Hashimoto thyroiditis in hormone replacement 
treatment (no relevant comorbidity was known).
Under ultrasound guidance, a 3-cm hypoechoic lesion 
was visualized in the left malar region and fine-needle-
aspiration biopsy (FNAB) was performed. Cytological 
examination showed numerous Red Blood Cells, some 
lymphoid small B- and T-cells, plasma cells with no poly-
clonal atypia and a population of small-sized cells with 
plasmacytoid cells with the following immunophenotype: 
S-100 protein + , GFAP ± , P63 ± , cytokeratin7-, suggest-
ing a salivary origin. However, a more precise diagnosis 
was not possible because of the small amount of material 
available.
The following month, Magnetic Resonance Imag-
ing (MRI) with intravenous paramagnetic contrast 
(Gadobutrol) was performed (Fig.  1). T1-weighted 
(T1w), T2-weighted (T2w), fat-saturated Short-TI Inver-
sion Recovery (STIR), Diffusion-Weighted Imaging 
(DWI), and T1w sequences after contrast administration 
were acquired. It revealed the presence of a solid poly-
lobate lesion located around the left parotid duct, with 
an antero-inferior component of 13 × 13 × 15 mm in the 
soft tissues adjacent to the buccinators, and another com-
ponent of about 22 × 27 × 29 mm in the buccal fat pad 
(Fig. 2) extending into the infratemporal fossa up to the 
pterygo-maxillary fissure, which exerted a mass effect on 
Fig. 1  Anatomy of the buccal space
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the masticatory muscles and the posterolateral wall of 
the maxillary sinus. The mass showed contrast medium 
uptake and diffusion restriction (apparent diffusion coef-
ficient, ADC = 0.9). Notably, the lesion displayed hyper-
intense signal compared to muscles in T1w sequences 
and hypointensity on T2w sequences. Some enlarged oval 
lymph nodes with progressive contrast enhancement were 
present in the left fifth cervical level. Overall, the MRI 
findings were suggestive of a malignant lesion that the 
radiologists assumed to have arisen from minor salivary 
glands on the basis of the anamnesis of the patient and of 
the epidemiology of neoplasms in this region.
The T1 hyperintensity was referred to possible blood 
residues in consideration of the recent bioptic procedure.
Surgical exeresis was performed 2 weeks later. Intraoral 
access through the gingival fornix was obtained. The 
lesion, which extended to the pterygo-maxillary fis-
sure, did not adhere to the surrounding tissues and was 
Fig. 2  Magnetic resonance 
imaging revealed a solid mass 
located in the left buccal 
space. a The lesion (arrow) 
showed a focal component with 
high signal intensity on axial 
T1-weighted imaging and b low 
signal intensity on T2-weighted 
imaging and c on fat-saturated 
T2 STIR sequences. d Diffu-
sion-weighted imaging revealed 
a restricted diffusion change 
with e low apparent diffusion 
coefficient of 0.9. f After intra-
venous contrast administration, 
the lesion showed increased 




easily removed. It was partially solid, with a colliquated 
component.
Histological examination showed the presence of fibro-
connective and lymphatic tissue containing malignant neo-
plastic cells compatible with a nodule of melanoma inside 
the buccal fat pad (Fig. 3).
Gene mutation analysis for c-KIT and BRAF was per-
formed: c-KIT was Wild Type (WT), while V600 mutation 
of BRAF exon 15 was found.
[F-18]FDG PET-CT (Fig. 4) revealed multiple localiza-
tions of pathological radiotracer hyper-accumulation: bilat-
eral suprahyoid and axillary lymph nodes, fifth liver seg-
ment, right adrenal gland, multiple abdominal solid lesions 
(perigastric, left psoas muscle, right iliac fossa), various 
subcutaneous, and muscular tissue localizations (left and 
right thigh and gluteus, right pectoral muscle, right masseter, 
and right fourth toe).
Full-body computed tomography (CT) with intravenous 
contrast was then performed, with the following results: no 
encephalic lesions; 2-cm left cervical lymph node (LN); 
5-mm left paracardiac micronodule; 7-cm LN conglomerate 
in the left axillary region; bilateral adrenal lesions (3.5 cm 
on the right side; 2 cm on the left); multiple enlarged mes-
enteric LNs, the largest of about 2 cm; 2.8-cm lesion in the 
left psoas muscle.
Dermatological examination revealed a 2-cm ulcerated 
cutaneous lesion on the distal phalanx of the left fifth fin-
ger, compatible with a primitive localization. The patient 
reported having it for about 1 year but never investigating it. 
Incisional biopsy of the lesion was performed, and histologi-
cal examination confirmed the presence of melanoma cells 
with V600E mutation of BRAF gene.
Immediately afterwards, treatment was begun with Dab-
rafenib 300 mg/die and Trametinib 2 mg/die.
Fig. 3  Microscopic pictures 
of the surgical specimen. 
a–d H&E stain at increas-
ing magnification (respec-
tively, × 40, × 100, × 200, 
and × 400) showing proliferating 
atypical cells containing coarse-
brownish granules suspected to 
be melanin; e, f, respectively, 
S-100 and SOX10 immunohis-
tochemical stains confirming 
the diagnosis of melanoma
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Two follow-up full-body CTs at 2 and 6 months were per-
formed and showed significant size reduction of the axillary 
and abdominal LNs, of the adrenal and mesenteric localiza-
tions, and disappearance of the thoracic nodules.
Discussion
A variety of processes can occur in the buccal space, such 
as infections, developmental lesions, and tumoral processes.
Neoplastic lesions in this area origin most commonly 
from minor salivary glands, such as pleomorphic adenoma, 
adenoid cystic carcinoma, acinic cell carcinoma, and 
mucoepidermoid carcinoma.
The most frequent benign glandular tumor is PA, which 
consists of both mesodermal and glandular tissue [3]. It has 
smooth, rounded margins and shows low signal intensity 
on T1w image, high T2 signal intensity, and no diffusion 
restriction on DWI.
The most common malignant glandular tumor is adenoid 
cystic carcinoma. Some authors have suggested that lesions 
with low or intermediate T2-hyperintensity or invading 
surrounding tissues tend to be more aggressive, whereas 
lesions characterized by high signal intensity in T2w 
sequences have lower cellularity and better prognosis [14].
Other tumors can originate from connective, muscular, 
neural, and lymphatic tissue, such as rhabdomyosarcomas 
and neurofibromas [5]; rhabdomyosarcomas appear as mus-
cle density masses at CT and are hyperintense relative to 
muscles on T2w MRI often showing bone destruction [15], 
while neurofibromas show low intensity on T1w imaging 
and high intensity on T2w imaging and are often associated 
with neurofibromatosis. Single neurofibromas characteris-
tically show the target sign with peripheral hyperintensity 
[15].
Usually, in diffusion-weighted MRI, the ADC of malig-
nant neoplasms of the head and neck regions is lower than 
that of benign tumors, and it is an important tool in guiding 
the diagnostic process [16].
Metastatic malignant melanoma is an uncommon head 
and neck neoplasm. The most frequent localizations of mela-
noma metastases are lymph nodes (73.6%), lungs (71.3%), 
liver (58.3%), brain (49.1%), bone (48.6%), heart (47.2%), 
Fig. 4  [F-18]FDG PET-CT 
reveals avid FDG uptake by 
the left buccal space lesion 
(a). Multiple pathological 
radiotracer hyper-accumulation 
localizations were present, such 
as in a voluminous left axillary 
lymph node (b), a perigastric 
solid lesion (c), and in the mus-
cular tissue of the left thigh (d)
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adrenal glands (46.8%), and gastrointestinal tract (43.5%) 
[17].
Melanoma localized in the oral cavity and surrounding 
anatomical regions, such as the buccal fat pad, accounts for 
0.2–8% of the total cases of melanomas of the body [18]. 
However, most studies focus on primary malignant mela-
noma, while secondary localization of melanoma in this 
region has been very rarely reported in the literature, with 
only one study describing a metastatic melanoma in the 
tongue and, to the best of our knowledge, no reports at all of 
the secondary melanomas in the buccal space [19].
Therefore, based on epidemiologic criteria, it is rather 
hard to diagnose metastatic melanoma in the buccal space 
in patients with an unknown primary tumor, as in our case.
Yet, MRI may be helpful in the identification of mela-
noma metastases [20].
Two main MRI patterns of melanoma can be identified: 
a melanocytic and amelanocytic pattern [21].
Lesions showing a melanocytic pattern, which is the more 
common one, are characterized by signal hyperintensity in 
T1w and hypointensity in T2w images. This is due to the 
presence of melanin and blood products inside the lesion, 
although some authors argue that the T1 hyperintensity is 
more relevantly associated with the presence of blood prod-
ucts [21–23].
Less commonly, malignant melanoma may show an 
amelanocytic (and therefore a specific) pattern, character-
ized by hypo- or isointensity in T1w images and hyper- or 
isointensity in T2w images [21], which is associated at histo-
pathological examination to lower quantity of melanin inside 
the lesion [24].
Macroscopically, metastatic malignant melanoma may 
present in different ways, ranging from small rapidly grow-
ing lesions which may initially go undetected or misrecog-
nized as artifacts, to showing a military pattern [25].
In our case, MRI showed a single lesion that exhibited 
diffusion restriction with ADC of 0.9 and high contrast 
medium uptake, characteristics suggestive of malignancy 
as it was proposed in the report.
Moreover, the mass was characterized by T1 hyperinten-
sity and T2 hypointensity, a behavior which may be attrib-
uted to the melanoma melanocytic pattern; however, it is 
not specific, since such features may be ascribed to other 
paraphysiological and pathological processes, including 
hemorrhages and proteinic fluid collections.
In this case, radiologists supposed that there was a hem-
orrhagic component inside the lesion, possibly a residue of 
the FNAB which had been performed 1 month and a half 
before. Yet, this was a mistake. In fact, only early subacute 
hemorrhage dating 3–7 days is featured by T1 hyperintensity 
and T2 hypointensity, whereas chronic hemorrhages dating 
more than 1 month are rather characterized by both T1 and 
T2 hypointensity (26).
Overlooking this aspect and ignoring a part of the anam-
nesis, radiologists assumed that they were dealing with a 
primitive buccal space neoplasm, namely with a malignant 
(minor) salivary gland tumor.
On the contrary, this case teaches that T1 hyperintensity 
and T2 hypointensity, when associated with other malig-
nancy features in buccal space lesion such as low ADC 
values and contrast enhancement, should always evoke the 
suspicion of melanoma, provided that no biopsy was per-
formed and no trauma occurred in the 3–7 days before MRI 
examination.
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